MUTATIONS AND POLYMORPHISMS OF BCL-2

摘要

This invention relates generally to the analytical testing of tissue samples in vitro, and more particularly to aspects of genetic polymorphisms and mutations of the BCL2 gene. The invention provides new BCL2 mutations and SNPs, useful in the diagnosis and treatment of subjects in need thereof. Accordingly, the various aspects of the present invention relate to polynucleotides encoding the BCL2 mutations of the invention, expression vectors encoding the BCL2 mutant polypeptides of the invention and organisms that express the BCL2 mutant and polymorphic polynucleotides and/or BCL2 mutant/polymorphic polypeptides of the invention. The various aspects of the present invention further relate to diagnostic/theranostic methods and kits that use the BCL2 mutations and polymorphisms of the invention to identify individuals predisposed to disease or to classify individuals with regard to drug responsiveness, side effects, or optimal drug dose.